Scarica l'app Stockscreener
23.03
1.14%
0.26
Dopo l'orario di chiusura:
23.20
0.17
+0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SDGR Giù?
Forum
Previsione
Precedente Chiudi:
$22.77
Aprire:
$23.17
Volume 24 ore:
388.46K
Relative Volume:
0.34
Capitalizzazione di mercato:
$1.48B
Reddito:
$193.35M
Utile/perdita netta:
$-177.58M
Rapporto P/E:
-9.40
EPS:
-2.45
Flusso di cassa netto:
$-172.43M
1 W Prestazione:
+8.38%
1M Prestazione:
+13.17%
6M Prestazione:
-5.65%
1 anno Prestazione:
+1.59%
Intervallo 1D:
$23.00
$23.39
Intervallo di 1 settimana:
$21.30
$23.75
Portata 52W:
$16.60
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Nome
Schrodinger Inc
Settore
Industria
Telefono
503-299-1150
Indirizzo
1540 BROADWAY, NEW YORK, NY
Confronta SDGR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
23.03 | 1.67B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
286.01 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.86 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.91 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.00 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.96 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Ripresa | Piper Sandler | Overweight |
| 2022-12-19 | Iniziato | Goldman | Neutral |
| 2022-03-01 | Iniziato | Citigroup | Buy |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Iniziato | Piper Sandler | Overweight |
| 2021-11-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-13 | Iniziato | Berenberg | Buy |
| 2021-09-01 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Iniziato | Craig Hallum | Buy |
| 2020-11-23 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-10-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-02 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-02 | Iniziato | Jefferies | Hold |
| 2020-03-02 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Schrodinger Inc Borsa (SDGR) Ultime notizie
Is Schrödinger Inc. a good long term investmentPowerful market insights - Autocar Professional
Schrodinger, Inc. (SDGR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
Schrödinger Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
What drives Schrödinger Inc. stock priceTremendous gains - Autocar Professional
What analysts say about Schrödinger Inc. stockSuperior stock growth - jammulinksnews.com
Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - Yahoo Finance
When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration By Investing.com - Investing.com Nigeria
Schrodinger stock maintains Buy rating at Citi on Ajax collaboration By Investing.com - Investing.com Canada
Schrodinger stock maintains Buy rating at Citi on Ajax collaboration - Investing.com
Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration - Investing.com
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Barchart.com
What makes Schrödinger Inc. stock price move sharplyMoney Making Low Risk Plans - beatles.ru
Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock - MSN
BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
(SDGR) On The My Stocks Page - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent
Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505 - MSN
Schrodinger stock rating assumed by Morgan Stanley at Equalweight - Investing.com India
Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert
Schrödinger gets Fast Track status for SGR-1505 - MSN
Schrödinger (SDGR) Gains FDA Fast Track for MALT1 Inhibitor - GuruFocus
Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia | SDGR Stock News - GuruFocus
Schrödinger gets Fast Track status for SGR-1505 (SDGR:NASDAQ) - Seeking Alpha
Schrodinger Announces Board Elections and Approvals - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger - Bluefield Daily Telegraph
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | PRN_FinancialWrapper | PR Newswire - FinancialContent
Where are the Opportunities in (SDGR) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, ... - Eagle-Tribune
Harbor Capital Advisors Inc. Grows Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrodinger Inc Azioni (SDGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):